Clinical Research Details Clinical Research GS-US-445-4189- A Randomized, Phase 2, Double-blind, Placebo-controlled Study to Assess the Safety and Efficacy of Filgotinib, GS-9876 and GS-4059 in Adult Subjects with Active Sjogren’s Syndrome Open Enrollment Contact Name: Sarah WaltersContact Phone: (904) 633-0071Contact Email: sarah.walters@jax.ufl.edu Investigators Gurjit S. Kaeley, M.B.B.S. (M.D.) Medicine